Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/9688309

Int. J. Cancer 1998 Aug 31 77 5 747-54

Download in:

View as

General Info

PMID
9688309